Héctor González‐Pacheco

ORCID: 0000-0002-4370-9963
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Mechanical Circulatory Support Devices
  • Cardiac Imaging and Diagnostics
  • Heart Failure Treatment and Management
  • Cardiac Arrest and Resuscitation
  • Cardiac Structural Anomalies and Repair
  • Cardiac Valve Diseases and Treatments
  • Cardiovascular Function and Risk Factors
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 Clinical Research Studies
  • Adipokines, Inflammation, and Metabolic Diseases
  • Coronary Interventions and Diagnostics
  • Kawasaki Disease and Coronary Complications
  • Cardiac electrophysiology and arrhythmias
  • Lipoproteins and Cardiovascular Health
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Aortic Disease and Treatment Approaches
  • Coronary Artery Anomalies
  • Cardiac Health and Mental Health
  • Cardiac Arrhythmias and Treatments
  • Aortic aneurysm repair treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Disease and Adiposity
  • Ultrasound in Clinical Applications
  • Congenital Heart Disease Studies

Instituto Nacional de Cardiología
2016-2025

Digestive Care (United States)
2002-2025

Corona (Poland)
2002-2025

Instituto Nacional de Cardiologia
1999-2024

Ospedale Santa Corona
2019-2024

Artistic Realization Technologies
2023-2024

Centro Hospitalario Pereira Rossell
2005-2020

Impact
2020

Universidad Autónoma Metropolitana
2016-2017

RELX Group (Netherlands)
2015

Systemic venous congestion is associated with an increased risk of acute kidney injury (AKI) in critically ill patients. Venous Excess Ultrasound Score (VExUS) has been proposed as a non-invasive score to assess systemic congestion. We aimed evaluate the association between VExUS and AKI patients coronary syndrome (ACS).This prospective study including diagnosis ACS (both ST elevation non-ST ACS). was performed during first 24 h hospital stay. Patients were classified according presence...

10.1093/ehjacc/zuad048 article EN European Heart Journal Acute Cardiovascular Care 2023-05-08

Many attempts have been proposed to evaluate the linkage between oral–gut–liver axis and mechanisms related diseases’ establishment. One of them is oral microbiota translocation into bloodstream, liver, gut, promoting a host dysbiosis triggering presence some metabolites such as trimethylamine N-oxide (TMAO), known risk marker for cardiovascular disease, especially myocardial infarction (MI). In present pilot study, involvement TMAO has considered an independent component standard factors...

10.1155/2024/3985731 article EN cc-by Mediators of Inflammation 2024-02-20

Objectives To evaluate the mid‐term outcomes, and aortic remodeling in Marfan syndrome (MFS) patients with type B dissection that were treated endovascular repair. Background MFS is a relative contraindication to thoracic repair (TEVAR). Mid‐term outcomes data after TEVAR are limited, occurrence of late events remains unclear. Methods Of 89 underwent between September 2002 February 2011, 10 follow‐up fulfilled Ghent criteria for complicated dissection. High risk open surgery was documented...

10.1002/ccd.24725 article EN Catheterization and Cardiovascular Interventions 2013-04-10

Background: MiR-155 plays a role in inflammatory pathways and cardiovascular diseases, though its relationship with inflammation, atherosclerosis, outcomes ST-elevation myocardial infarction (STEMI) is not well established.Objective:To investigate associations between miR-155 levels, atherosclerotic burden, major adverse events (MACE) STEMI patients.Methods: Sixty-nine patients 16 healthy controls were recruited from specialized university-affiliated center.MiR-155 expression serum...

10.24875/ric.24000189 article EN cc-by-nc-nd Revista de investigaci�n Cl�nica 2025-01-14

Background Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI) with high mortality. Few studies have examined the selection and subsequent choice vasoactive agents in CS. This study investigates impact drug use in-hospital outcomes among AMI-CS. Materials methods A total 309 patients who underwent pulmonary artery catheterization between 2006 2021 were categorized by number drugs used (0–1, 2, or >2). Clinical 24 h hemodynamic data analyzed. Primary...

10.3389/fcvm.2025.1461714 article EN cc-by Frontiers in Cardiovascular Medicine 2025-02-13

We aimed to assess the performance of an artificial intelligence-electrocardiogram (AI-ECG)-based model capable detecting acute coronary occlusion myocardial infarction (ACOMI) in setting patients with syndrome (ACS). This was a prospective, observational, longitudinal, and single-center study including initial diagnosis ACS (both ST-elevation [STEMI] & non-ST-segment elevation [NSTEMI]). To train deep learning recognizing ACOMI, manual digitization patient's ECG conducted using smartphone...

10.24875/acm.24000195 article EN cc-by-nc-nd Archivos de cardiología de México 2025-02-28

Take home messages 1. Despite being considered a benign tumor, the high reported incidence of embolic events increasingly warrants surgical resection, regardless size, especially in patients with history cardiovascular risk factors. 2. Multimodal imaging evaluation plays crucial role distinguishing intracardiac masses, relying on physician's ability to discern characteristic findings. Proper assessment leads appropriate management decisions based suggestive Cardiac tumors are rare and should...

10.1111/echo.70113 article EN Echocardiography 2025-03-01

Among patients with coronary artery disease (CAD), 80%-90% present at least one conventional risk factor. On the other hand, lipid profile modification after a cardiovascular event related to acute syndrome (ACS) has been recognized. The prevalence of factors and time admission in ACS significant CAD (stenosis ≥50%) determined through angiography is not well described.We studied 3,447 diagnosis stenosis ≥50%, as shown o n angiography. We recorded presence factors, including smoking,...

10.2147/tcrm.s67945 article EN cc-by-nc Therapeutics and Clinical Risk Management 2014-10-01

Background In animal models of pulmonary arterial hypertension (PAH), angiotensin-converting enzyme (ACE)2 and angiotensin (Ang)-(1–7) have been shown to vasodilatory, antiproliferative, antifibrotic antihypertrophic properties. However, the status role ACE2-Ang(1–7) axis in human PAH is incompletely understood. Methods We studied 85 patients with a diagnosis distinct aetiologies. 55 healthy blood donors paired for age sex served as controls. Blood samples were obtained from artery during...

10.1183/13993003.02416-2019 article EN European Respiratory Journal 2020-04-02

Acute Kidney Injury (AKI), a common complication of acute coronary syndromes (ACS), is associated with higher mortality and longer hospital stays. The role cytokines other mediators unknown in AKI induced by an ACS (ACS-AKI), leading to several unanswered questions. worsening renal function usually seen as dichotomous phenomenon instead dynamic change, so evaluating changes the time may provide valuable information ACS-AKI setting. aim this study was explore inflammatory factors de novo...

10.1186/s12872-017-0640-0 article EN cc-by BMC Cardiovascular Disorders 2017-07-26

Cytidine-5'-diphosphocholine (CDP-choline) participates as an intermediary in the synthesis of phosphatidylcholine, essential component cellular membranes. Citicoline treatment has shown beneficial effects cerebral ischemia, but its potential to diminish reperfusion damage liver not been explored. In this work, we evaluated hepatoprotective effect citicoline and possible association with inflammatory/oxidative stress mitochondrial function because they are main features damage....

10.1002/lt.25179 article EN Liver Transplantation 2018-04-21
Coming Soon ...